Indianapolis, IN, United States of America

Thomas Hurley

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Indiana University, University of Michigan. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Thomas Hurley. Retrieved from https://idiyas.com/inventor/thomas-hurley

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Thomas Hurley: Innovator in Medicinal Chemistry

Introduction

Thomas Hurley is a prominent inventor based in Indianapolis, IN (US). He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on small molecule inhibitors.

Latest Patents

Hurley's most notable patent is titled "Small molecule inhibitors of ALDH and uses thereof." This invention introduces a new class of small molecules characterized by a thiopyrimidinone structure. These molecules function as inhibitors of the ALDH protein and have potential therapeutic applications for the treatment of cancer and other diseases. He holds 1 patent in this area.

Career Highlights

Throughout his career, Thomas Hurley has worked with esteemed institutions such as Indiana University and the University of Michigan. His research has focused on developing novel therapeutic strategies that leverage the unique properties of small molecules.

Collaborations

Hurley has collaborated with notable colleagues, including Kun Yang and Ronald J Buckanovich. These partnerships have furthered his research and contributed to advancements in medicinal chemistry.

Conclusion

In summary, Thomas Hurley is a dedicated inventor whose work in medicinal chemistry has the potential to impact cancer treatment significantly. His innovative approach to small molecule inhibitors showcases the importance of research in developing new therapeutic options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…